Generalized Tonic Clonic Seizure: Clinical Trials

3 trials for Generalized Tonic Clonic Seizure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 2 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 31Active not recruiting 1

Follow Generalized Tonic Clonic Seizure: new trials by email Literature Review of Generalized Tonic Clonic Seizure trials Research Report on Generalized Tonic Clonic Seizure

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RNS System NAUTILUS Study
Responsive stimulation, Sham stimulation - Epilepsy, Idiopathic Generalized Epilepsy
Not applicableCompletedNeuroPace1002022-08-092026-06-08
A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.
Fenfluramine, Placebo - CDKL5 Deficiency Disorder, Generalized Tonic Clonic Seizure
Phase 3Active not recruitingZogenix, Inc.872022-03-082026-04-29
Novel Helmet Design in Patients With Seizures
Hövding inflatable helmet - Drug Resistant Epilepsy, Drop Seizures
Not applicableCompletedMichael A. Gelfand, MD, PhD92017-08-142025-01-09

Narrower conditions

Epilepsy, Tonic-Clonic (3)  ·  Seizures (2)  ·  CDKL5 deficiency disorder (1)  ·  Drug Resistant Epilepsy (1)  ·  Epilepsy (1)  ·  Epilepsy, Idiopathic Generalized (1)  ·  Spasms, Infantile (1)  ·  Syncope (1)

Broader conditions

Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Epilepsy, Generalized (3)  ·  Nervous System Diseases (3)  ·  Epilepsy (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Consciousness Disorders (1)  ·  Epileptic Syndromes (1)  ·  Neurobehavioral Manifestations (1)  ·  Unconsciousness (1)

Interventions

Fenfluramine (1)

Sponsors

Michael A. Gelfand, MD, PhD (1)  ·  NeuroPace (1)  ·  Zogenix, Inc. (1)

Countries

United States (3)  ·  Austria (1)  ·  Belgium (1)  ·  Georgia (1)  ·  Germany (1)  ·  Ireland (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Portugal (1)  ·  Spain (1)  ·  United Arab Emirates (1)  ·  United Kingdom (1)

Top investigators

Martha Morrell, MD (1)  ·  Michael Gelfand, MD, PhD (1)

NIH funding

2023 (1)